文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

三维超声与锥形束CT在前列腺癌伴或不伴盆腔淋巴结照射的图像引导放疗中配准准确性的影响因素分析

Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.
PubMed 文献 · Radiat Oncol · 2019-01-29

本研究分析了24例和25例接受或不接受盆腔淋巴结照射的前列腺癌患者共586次和580次治疗中,三维超声与锥形束CT配准的差异。结果显示年龄、照射区域、三维超声模式和膀胱体积是影响配准差异的重要因素,三维超声引导对年轻、未接受盆腔淋巴结照射且膀胱体积控制较好的患者更可行。

要点

  • 三维超声与锥形束CT配准在上下、左右、前后方向的平均差异分别为-0.28±5.28毫米、-0.16±3.48毫米和-0.47±4.31毫米。
  • 配准差异在三个方向上小于5毫米的比例,接受与未接受盆腔淋巴结照射的患者分别为64.4%与70.1%、84.9%与89.2%、75.9%与79.1%。
  • 年龄小于70岁、未接受盆腔淋巴结照射、经会阴超声引导且膀胱体积小于300毫升的患者,配准差异至少在一个方向上显著更小。

核心结论

  • 年龄、照射区域、三维超声模式和膀胱体积是可能影响三维超声与锥形束CT配准差异的重要因素。
  • 三维超声引导对较年轻、治疗中膀胱体积控制较好且未接受盆腔淋巴结照射的前列腺癌患者更可行。

研究设计与样本

  • 对24例接受盆腔淋巴结照射和25例未接受盆腔淋巴结照射的前列腺癌患者,分别分析586次和580次治疗中超声/超声与锥形束CT/CT配准的差异。
  • 评估可能影响配准差异的临床因素。

主要发现

  • 超声/超声与锥形束CT/CT配准的平均差异在上下、左右、前后方向分别为-0.28±5.28毫米、-0.16±3.48毫米和-0.47±4.31毫米。
  • 配准差异在纵向、横向和垂直方向分别小于5毫米的比例,接受盆腔淋巴结照射的患者为64.4%、84.9%和75.9%,未接受盆腔淋巴结照射的患者为70.1%、89.2%和79.1%。
  • 年龄小于70岁、未接受盆腔淋巴结照射、经会阴超声引导且膀胱体积小于300毫升的患者,配准差异至少在一个方向上显著更小。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Three-dimensional ultrasound (3DUS) is an attractive option in image-guided radiotherapy (IGRT) for prostate cancer (PCa) patients. However, the potential factors influencing the accuracy of 3DUS in comparison with cone-beam CT (CBCT) in IGRT for PCa patients haven't been clearly identified. METHODS: The differences between US/US and CBCT/CT registrations were analyzed over 586 and 580 sessions for 24 and 25 PCa patients treated with or without pelvic lymph node irradiation, respectively. The clinical factors that may influence registration differences were also evaluated. RESULTS: The average discrepancies between US/US and CBCT/CT registrations were - 0.28 ± 5.28 mm, - 0.16 ± 3.48 mm, and - 0.47 ± 4.31 mm in the superior-inferior (SI), left-right (LR), and anterior-posterior (AP) directions, respectively. The discrepancies were respectively less than 5 mm longitudinally, laterally, and vertically in 64.4 and 70.1%, 84.9 and 89.2%, and 75.9 and 79.1% of the patients treated with or without pelvic lymph node irradiation, respectively. The registration differences were significantly smaller at least in one direction in patients younger than 70 years, without pelvic lymph node irradiation, guided by transperineal ultrasonography and had a bladder volume smaller than 300 mL. CONCLUSIONS: Age, irradiated regions, 3DUS modality, and bladder volume are important factors that may influence the differences between US/US and CBCT/CT registrations. 3DUS guidance is more feasible for younger PCa patients with a better control of bladder volume during the treatment and those who did not undergo pelvic lymph node irradiation.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zhou S, Luo L, Li J, et al. Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation. Radiat Oncol. 2019. PMID: 30696488. doi:10.1186/s13014-019-1217-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。